HEADER TRANSPORT PROTEIN/INHIBITOR 19-MAY-21 7MXY TITLE CRYO-EM STRUCTURE OF PFFNT-INHIBITOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: FORMATE-NITRITE TRANSPORTER; COMPND 3 CHAIN: A, B, C, D, E; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM (ISOLATE 3D7); SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: ISOLATE 3D7; SOURCE 5 GENE: PF3D7_0316600; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS PFFNT, LACTATE TRANSPORTER, PFFNT-MMV007839 COMPLEX, TRANSPORT KEYWDS 2 PROTEIN-INHIBITOR COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR E.W.YU,C.SU,M.LYU REVDAT 2 29-MAY-24 7MXY 1 REMARK REVDAT 1 08-DEC-21 7MXY 0 JRNL AUTH M.LYU,C.SU,J.W.KAZURA,E.W.YU JRNL TITL STRUCTURAL BASIS OF TRANSPORT AND INHIBITION OF THE JRNL TITL 2 PLASMODIUM FALCIPARUM TRANSPORTER PFFNT JRNL REF EMBO REP V. 22 51628 2021 JRNL REFN ISSN 1469-221X JRNL PMID 33471955 JRNL DOI 10.15252/EMBR.202051628 REMARK 2 REMARK 2 RESOLUTION. 2.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.180 REMARK 3 NUMBER OF PARTICLES : 104419 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7MXY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1000256944. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : PFFNT-INHIBITOR COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 3800.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 PRO A 3 REMARK 465 ASN A 4 REMARK 465 ASN A 5 REMARK 465 SER A 6 REMARK 465 LYS A 7 REMARK 465 TYR A 8 REMARK 465 LYS A 292 REMARK 465 ARG A 293 REMARK 465 ASP A 294 REMARK 465 ASN A 295 REMARK 465 ASN A 296 REMARK 465 ASP A 297 REMARK 465 ALA A 298 REMARK 465 GLN A 299 REMARK 465 MET A 300 REMARK 465 LYS A 301 REMARK 465 SER A 302 REMARK 465 LEU A 303 REMARK 465 SER A 304 REMARK 465 ILE A 305 REMARK 465 GLU A 306 REMARK 465 LEU A 307 REMARK 465 ARG A 308 REMARK 465 ASN A 309 REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 PRO B 3 REMARK 465 ASN B 4 REMARK 465 ASN B 5 REMARK 465 SER B 6 REMARK 465 LYS B 7 REMARK 465 TYR B 8 REMARK 465 VAL B 9 REMARK 465 LEU B 10 REMARK 465 ASP B 11 REMARK 465 ARG B 293 REMARK 465 ASP B 294 REMARK 465 ASN B 295 REMARK 465 ASN B 296 REMARK 465 ASP B 297 REMARK 465 ALA B 298 REMARK 465 GLN B 299 REMARK 465 MET B 300 REMARK 465 LYS B 301 REMARK 465 SER B 302 REMARK 465 LEU B 303 REMARK 465 SER B 304 REMARK 465 ILE B 305 REMARK 465 GLU B 306 REMARK 465 LEU B 307 REMARK 465 ARG B 308 REMARK 465 ASN B 309 REMARK 465 MET C 1 REMARK 465 PRO C 2 REMARK 465 PRO C 3 REMARK 465 ASN C 4 REMARK 465 ASN C 5 REMARK 465 SER C 6 REMARK 465 LYS C 7 REMARK 465 TYR C 8 REMARK 465 VAL C 9 REMARK 465 LEU C 10 REMARK 465 ASP C 11 REMARK 465 SER C 291 REMARK 465 LYS C 292 REMARK 465 ARG C 293 REMARK 465 ASP C 294 REMARK 465 ASN C 295 REMARK 465 ASN C 296 REMARK 465 ASP C 297 REMARK 465 ALA C 298 REMARK 465 GLN C 299 REMARK 465 MET C 300 REMARK 465 LYS C 301 REMARK 465 SER C 302 REMARK 465 LEU C 303 REMARK 465 SER C 304 REMARK 465 ILE C 305 REMARK 465 GLU C 306 REMARK 465 LEU C 307 REMARK 465 ARG C 308 REMARK 465 ASN C 309 REMARK 465 MET D 1 REMARK 465 PRO D 2 REMARK 465 PRO D 3 REMARK 465 ASN D 4 REMARK 465 ASN D 5 REMARK 465 SER D 6 REMARK 465 LYS D 7 REMARK 465 TYR D 8 REMARK 465 SER D 291 REMARK 465 LYS D 292 REMARK 465 ARG D 293 REMARK 465 ASP D 294 REMARK 465 ASN D 295 REMARK 465 ASN D 296 REMARK 465 ASP D 297 REMARK 465 ALA D 298 REMARK 465 GLN D 299 REMARK 465 MET D 300 REMARK 465 LYS D 301 REMARK 465 SER D 302 REMARK 465 LEU D 303 REMARK 465 SER D 304 REMARK 465 ILE D 305 REMARK 465 GLU D 306 REMARK 465 LEU D 307 REMARK 465 ARG D 308 REMARK 465 ASN D 309 REMARK 465 MET E 1 REMARK 465 PRO E 2 REMARK 465 PRO E 3 REMARK 465 ASN E 4 REMARK 465 ASN E 5 REMARK 465 SER E 6 REMARK 465 LYS E 7 REMARK 465 TYR E 8 REMARK 465 ARG E 290 REMARK 465 SER E 291 REMARK 465 LYS E 292 REMARK 465 ARG E 293 REMARK 465 ASP E 294 REMARK 465 ASN E 295 REMARK 465 ASN E 296 REMARK 465 ASP E 297 REMARK 465 ALA E 298 REMARK 465 GLN E 299 REMARK 465 MET E 300 REMARK 465 LYS E 301 REMARK 465 SER E 302 REMARK 465 LEU E 303 REMARK 465 SER E 304 REMARK 465 ILE E 305 REMARK 465 GLU E 306 REMARK 465 LEU E 307 REMARK 465 ARG E 308 REMARK 465 ASN E 309 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 91 -7.78 -54.36 REMARK 500 TYR A 212 -39.22 -39.39 REMARK 500 ILE A 271 -61.57 -104.82 REMARK 500 ALA B 79 -5.62 74.65 REMARK 500 PRO B 91 -8.68 -54.99 REMARK 500 ASN B 164 33.55 -97.51 REMARK 500 THR B 246 -169.14 -78.61 REMARK 500 VAL C 148 -60.87 -96.05 REMARK 500 THR C 246 -166.86 -79.76 REMARK 500 ASP D 11 76.38 -158.66 REMARK 500 ALA D 270 -60.16 -93.18 REMARK 500 GLU D 289 35.74 -96.82 REMARK 500 LYS E 119 36.67 70.10 REMARK 500 PHE E 146 -70.05 -55.73 REMARK 500 VAL E 148 -63.43 -91.06 REMARK 500 ASN E 245 60.76 61.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HV6 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HV6 B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HV6 C 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HV6 D 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HV6 E 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-24076 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF PFFNT-INHIBITOR COMPLEX DBREF 7MXY A 1 309 UNP O77389 O77389_PLAF7 1 309 DBREF 7MXY B 1 309 UNP O77389 O77389_PLAF7 1 309 DBREF 7MXY C 1 309 UNP O77389 O77389_PLAF7 1 309 DBREF 7MXY D 1 309 UNP O77389 O77389_PLAF7 1 309 DBREF 7MXY E 1 309 UNP O77389 O77389_PLAF7 1 309 SEQRES 1 A 309 MET PRO PRO ASN ASN SER LYS TYR VAL LEU ASP PRO VAL SEQRES 2 A 309 SER ILE LYS SER VAL CYS GLY GLY GLU GLU SER TYR ILE SEQRES 3 A 309 ARG CYS VAL GLU TYR GLY LYS LYS LYS ALA HIS TYR SER SEQRES 4 A 309 ASN LEU ASN LEU LEU ALA LYS ALA ILE LEU ALA GLY MET SEQRES 5 A 309 PHE VAL GLY LEU CYS ALA HIS ALA SER GLY ILE ALA GLY SEQRES 6 A 309 GLY LEU PHE TYR TYR HIS LYS LEU ARG GLU ILE VAL GLY SEQRES 7 A 309 ALA SER MET SER VAL PHE VAL TYR GLY PHE THR PHE PRO SEQRES 8 A 309 ILE ALA PHE MET CYS ILE ILE CYS THR GLY SER ASP LEU SEQRES 9 A 309 PHE THR GLY ASN THR LEU ALA VAL THR MET ALA LEU TYR SEQRES 10 A 309 GLU LYS LYS VAL LYS LEU LEU ASP TYR LEU ARG VAL MET SEQRES 11 A 309 THR ILE SER LEU PHE GLY ASN TYR VAL GLY ALA VAL SER SEQRES 12 A 309 PHE ALA PHE PHE VAL SER TYR LEU SER GLY ALA PHE THR SEQRES 13 A 309 ASN VAL HIS ALA VAL GLU LYS ASN HIS PHE PHE GLN PHE SEQRES 14 A 309 LEU ASN ASP ILE ALA GLU LYS LYS VAL HIS HIS THR PHE SEQRES 15 A 309 VAL GLU CYS VAL SER LEU ALA VAL GLY CYS ASN ILE PHE SEQRES 16 A 309 VAL CYS LEU ALA VAL TYR PHE VAL LEU THR LEU LYS ASP SEQRES 17 A 309 GLY ALA GLY TYR VAL PHE SER VAL PHE PHE ALA VAL TYR SEQRES 18 A 309 ALA PHE ALA ILE ALA GLY TYR GLU HIS ILE ILE ALA ASN SEQRES 19 A 309 ILE TYR THR LEU ASN ILE ALA LEU MET VAL ASN THR LYS SEQRES 20 A 309 ILE THR VAL TYR GLN ALA TYR ILE LYS ASN LEU LEU PRO SEQRES 21 A 309 THR LEU LEU GLY ASN TYR ILE ALA GLY ALA ILE VAL LEU SEQRES 22 A 309 GLY LEU PRO LEU TYR PHE ILE TYR LYS GLU HIS TYR TYR SEQRES 23 A 309 ASN PHE GLU ARG SER LYS ARG ASP ASN ASN ASP ALA GLN SEQRES 24 A 309 MET LYS SER LEU SER ILE GLU LEU ARG ASN SEQRES 1 B 309 MET PRO PRO ASN ASN SER LYS TYR VAL LEU ASP PRO VAL SEQRES 2 B 309 SER ILE LYS SER VAL CYS GLY GLY GLU GLU SER TYR ILE SEQRES 3 B 309 ARG CYS VAL GLU TYR GLY LYS LYS LYS ALA HIS TYR SER SEQRES 4 B 309 ASN LEU ASN LEU LEU ALA LYS ALA ILE LEU ALA GLY MET SEQRES 5 B 309 PHE VAL GLY LEU CYS ALA HIS ALA SER GLY ILE ALA GLY SEQRES 6 B 309 GLY LEU PHE TYR TYR HIS LYS LEU ARG GLU ILE VAL GLY SEQRES 7 B 309 ALA SER MET SER VAL PHE VAL TYR GLY PHE THR PHE PRO SEQRES 8 B 309 ILE ALA PHE MET CYS ILE ILE CYS THR GLY SER ASP LEU SEQRES 9 B 309 PHE THR GLY ASN THR LEU ALA VAL THR MET ALA LEU TYR SEQRES 10 B 309 GLU LYS LYS VAL LYS LEU LEU ASP TYR LEU ARG VAL MET SEQRES 11 B 309 THR ILE SER LEU PHE GLY ASN TYR VAL GLY ALA VAL SER SEQRES 12 B 309 PHE ALA PHE PHE VAL SER TYR LEU SER GLY ALA PHE THR SEQRES 13 B 309 ASN VAL HIS ALA VAL GLU LYS ASN HIS PHE PHE GLN PHE SEQRES 14 B 309 LEU ASN ASP ILE ALA GLU LYS LYS VAL HIS HIS THR PHE SEQRES 15 B 309 VAL GLU CYS VAL SER LEU ALA VAL GLY CYS ASN ILE PHE SEQRES 16 B 309 VAL CYS LEU ALA VAL TYR PHE VAL LEU THR LEU LYS ASP SEQRES 17 B 309 GLY ALA GLY TYR VAL PHE SER VAL PHE PHE ALA VAL TYR SEQRES 18 B 309 ALA PHE ALA ILE ALA GLY TYR GLU HIS ILE ILE ALA ASN SEQRES 19 B 309 ILE TYR THR LEU ASN ILE ALA LEU MET VAL ASN THR LYS SEQRES 20 B 309 ILE THR VAL TYR GLN ALA TYR ILE LYS ASN LEU LEU PRO SEQRES 21 B 309 THR LEU LEU GLY ASN TYR ILE ALA GLY ALA ILE VAL LEU SEQRES 22 B 309 GLY LEU PRO LEU TYR PHE ILE TYR LYS GLU HIS TYR TYR SEQRES 23 B 309 ASN PHE GLU ARG SER LYS ARG ASP ASN ASN ASP ALA GLN SEQRES 24 B 309 MET LYS SER LEU SER ILE GLU LEU ARG ASN SEQRES 1 C 309 MET PRO PRO ASN ASN SER LYS TYR VAL LEU ASP PRO VAL SEQRES 2 C 309 SER ILE LYS SER VAL CYS GLY GLY GLU GLU SER TYR ILE SEQRES 3 C 309 ARG CYS VAL GLU TYR GLY LYS LYS LYS ALA HIS TYR SER SEQRES 4 C 309 ASN LEU ASN LEU LEU ALA LYS ALA ILE LEU ALA GLY MET SEQRES 5 C 309 PHE VAL GLY LEU CYS ALA HIS ALA SER GLY ILE ALA GLY SEQRES 6 C 309 GLY LEU PHE TYR TYR HIS LYS LEU ARG GLU ILE VAL GLY SEQRES 7 C 309 ALA SER MET SER VAL PHE VAL TYR GLY PHE THR PHE PRO SEQRES 8 C 309 ILE ALA PHE MET CYS ILE ILE CYS THR GLY SER ASP LEU SEQRES 9 C 309 PHE THR GLY ASN THR LEU ALA VAL THR MET ALA LEU TYR SEQRES 10 C 309 GLU LYS LYS VAL LYS LEU LEU ASP TYR LEU ARG VAL MET SEQRES 11 C 309 THR ILE SER LEU PHE GLY ASN TYR VAL GLY ALA VAL SER SEQRES 12 C 309 PHE ALA PHE PHE VAL SER TYR LEU SER GLY ALA PHE THR SEQRES 13 C 309 ASN VAL HIS ALA VAL GLU LYS ASN HIS PHE PHE GLN PHE SEQRES 14 C 309 LEU ASN ASP ILE ALA GLU LYS LYS VAL HIS HIS THR PHE SEQRES 15 C 309 VAL GLU CYS VAL SER LEU ALA VAL GLY CYS ASN ILE PHE SEQRES 16 C 309 VAL CYS LEU ALA VAL TYR PHE VAL LEU THR LEU LYS ASP SEQRES 17 C 309 GLY ALA GLY TYR VAL PHE SER VAL PHE PHE ALA VAL TYR SEQRES 18 C 309 ALA PHE ALA ILE ALA GLY TYR GLU HIS ILE ILE ALA ASN SEQRES 19 C 309 ILE TYR THR LEU ASN ILE ALA LEU MET VAL ASN THR LYS SEQRES 20 C 309 ILE THR VAL TYR GLN ALA TYR ILE LYS ASN LEU LEU PRO SEQRES 21 C 309 THR LEU LEU GLY ASN TYR ILE ALA GLY ALA ILE VAL LEU SEQRES 22 C 309 GLY LEU PRO LEU TYR PHE ILE TYR LYS GLU HIS TYR TYR SEQRES 23 C 309 ASN PHE GLU ARG SER LYS ARG ASP ASN ASN ASP ALA GLN SEQRES 24 C 309 MET LYS SER LEU SER ILE GLU LEU ARG ASN SEQRES 1 D 309 MET PRO PRO ASN ASN SER LYS TYR VAL LEU ASP PRO VAL SEQRES 2 D 309 SER ILE LYS SER VAL CYS GLY GLY GLU GLU SER TYR ILE SEQRES 3 D 309 ARG CYS VAL GLU TYR GLY LYS LYS LYS ALA HIS TYR SER SEQRES 4 D 309 ASN LEU ASN LEU LEU ALA LYS ALA ILE LEU ALA GLY MET SEQRES 5 D 309 PHE VAL GLY LEU CYS ALA HIS ALA SER GLY ILE ALA GLY SEQRES 6 D 309 GLY LEU PHE TYR TYR HIS LYS LEU ARG GLU ILE VAL GLY SEQRES 7 D 309 ALA SER MET SER VAL PHE VAL TYR GLY PHE THR PHE PRO SEQRES 8 D 309 ILE ALA PHE MET CYS ILE ILE CYS THR GLY SER ASP LEU SEQRES 9 D 309 PHE THR GLY ASN THR LEU ALA VAL THR MET ALA LEU TYR SEQRES 10 D 309 GLU LYS LYS VAL LYS LEU LEU ASP TYR LEU ARG VAL MET SEQRES 11 D 309 THR ILE SER LEU PHE GLY ASN TYR VAL GLY ALA VAL SER SEQRES 12 D 309 PHE ALA PHE PHE VAL SER TYR LEU SER GLY ALA PHE THR SEQRES 13 D 309 ASN VAL HIS ALA VAL GLU LYS ASN HIS PHE PHE GLN PHE SEQRES 14 D 309 LEU ASN ASP ILE ALA GLU LYS LYS VAL HIS HIS THR PHE SEQRES 15 D 309 VAL GLU CYS VAL SER LEU ALA VAL GLY CYS ASN ILE PHE SEQRES 16 D 309 VAL CYS LEU ALA VAL TYR PHE VAL LEU THR LEU LYS ASP SEQRES 17 D 309 GLY ALA GLY TYR VAL PHE SER VAL PHE PHE ALA VAL TYR SEQRES 18 D 309 ALA PHE ALA ILE ALA GLY TYR GLU HIS ILE ILE ALA ASN SEQRES 19 D 309 ILE TYR THR LEU ASN ILE ALA LEU MET VAL ASN THR LYS SEQRES 20 D 309 ILE THR VAL TYR GLN ALA TYR ILE LYS ASN LEU LEU PRO SEQRES 21 D 309 THR LEU LEU GLY ASN TYR ILE ALA GLY ALA ILE VAL LEU SEQRES 22 D 309 GLY LEU PRO LEU TYR PHE ILE TYR LYS GLU HIS TYR TYR SEQRES 23 D 309 ASN PHE GLU ARG SER LYS ARG ASP ASN ASN ASP ALA GLN SEQRES 24 D 309 MET LYS SER LEU SER ILE GLU LEU ARG ASN SEQRES 1 E 309 MET PRO PRO ASN ASN SER LYS TYR VAL LEU ASP PRO VAL SEQRES 2 E 309 SER ILE LYS SER VAL CYS GLY GLY GLU GLU SER TYR ILE SEQRES 3 E 309 ARG CYS VAL GLU TYR GLY LYS LYS LYS ALA HIS TYR SER SEQRES 4 E 309 ASN LEU ASN LEU LEU ALA LYS ALA ILE LEU ALA GLY MET SEQRES 5 E 309 PHE VAL GLY LEU CYS ALA HIS ALA SER GLY ILE ALA GLY SEQRES 6 E 309 GLY LEU PHE TYR TYR HIS LYS LEU ARG GLU ILE VAL GLY SEQRES 7 E 309 ALA SER MET SER VAL PHE VAL TYR GLY PHE THR PHE PRO SEQRES 8 E 309 ILE ALA PHE MET CYS ILE ILE CYS THR GLY SER ASP LEU SEQRES 9 E 309 PHE THR GLY ASN THR LEU ALA VAL THR MET ALA LEU TYR SEQRES 10 E 309 GLU LYS LYS VAL LYS LEU LEU ASP TYR LEU ARG VAL MET SEQRES 11 E 309 THR ILE SER LEU PHE GLY ASN TYR VAL GLY ALA VAL SER SEQRES 12 E 309 PHE ALA PHE PHE VAL SER TYR LEU SER GLY ALA PHE THR SEQRES 13 E 309 ASN VAL HIS ALA VAL GLU LYS ASN HIS PHE PHE GLN PHE SEQRES 14 E 309 LEU ASN ASP ILE ALA GLU LYS LYS VAL HIS HIS THR PHE SEQRES 15 E 309 VAL GLU CYS VAL SER LEU ALA VAL GLY CYS ASN ILE PHE SEQRES 16 E 309 VAL CYS LEU ALA VAL TYR PHE VAL LEU THR LEU LYS ASP SEQRES 17 E 309 GLY ALA GLY TYR VAL PHE SER VAL PHE PHE ALA VAL TYR SEQRES 18 E 309 ALA PHE ALA ILE ALA GLY TYR GLU HIS ILE ILE ALA ASN SEQRES 19 E 309 ILE TYR THR LEU ASN ILE ALA LEU MET VAL ASN THR LYS SEQRES 20 E 309 ILE THR VAL TYR GLN ALA TYR ILE LYS ASN LEU LEU PRO SEQRES 21 E 309 THR LEU LEU GLY ASN TYR ILE ALA GLY ALA ILE VAL LEU SEQRES 22 E 309 GLY LEU PRO LEU TYR PHE ILE TYR LYS GLU HIS TYR TYR SEQRES 23 E 309 ASN PHE GLU ARG SER LYS ARG ASP ASN ASN ASP ALA GLN SEQRES 24 E 309 MET LYS SER LEU SER ILE GLU LEU ARG ASN HET HV6 A1001 30 HET HV6 B 401 30 HET HV6 C 401 30 HET HV6 D 401 30 HET HV6 E 401 30 HETNAM HV6 (Z)-4,4,5,5,5-PENTAKIS(FLUORANYL)-1-(4-METHOXY-2- HETNAM 2 HV6 OXIDANYL-PHENYL)-3-OXIDANYL-PENT-2-EN-1-ONE FORMUL 6 HV6 5(C12 H9 F5 O4) FORMUL 11 HOH *2(H2 O) HELIX 1 AA1 GLY A 21 TYR A 38 1 18 HELIX 2 AA2 SER A 39 PHE A 68 1 30 HELIX 3 AA3 TYR A 70 GLY A 78 1 9 HELIX 4 AA4 ALA A 79 PHE A 90 1 12 HELIX 5 AA5 PRO A 91 THR A 100 1 10 HELIX 6 AA6 LEU A 104 GLU A 118 1 15 HELIX 7 AA7 LYS A 122 VAL A 148 1 27 HELIX 8 AA8 ASN A 164 VAL A 178 1 15 HELIX 9 AA9 THR A 181 LEU A 206 1 26 HELIX 10 AB1 GLY A 209 GLY A 227 1 19 HELIX 11 AB2 HIS A 230 VAL A 244 1 15 HELIX 12 AB3 THR A 249 ILE A 255 1 7 HELIX 13 AB4 ASN A 257 ILE A 271 1 15 HELIX 14 AB5 GLY A 274 SER A 291 1 18 HELIX 15 AB6 GLY B 20 ALA B 36 1 17 HELIX 16 AB7 SER B 39 PHE B 68 1 30 HELIX 17 AB8 TYR B 70 GLY B 78 1 9 HELIX 18 AB9 ALA B 79 PHE B 90 1 12 HELIX 19 AC1 PRO B 91 CYS B 99 1 9 HELIX 20 AC2 LEU B 104 GLU B 118 1 15 HELIX 21 AC3 LYS B 122 SER B 152 1 31 HELIX 22 AC4 ASN B 164 HIS B 179 1 16 HELIX 23 AC5 THR B 181 LEU B 206 1 26 HELIX 24 AC6 ASP B 208 GLY B 227 1 20 HELIX 25 AC7 HIS B 230 VAL B 244 1 15 HELIX 26 AC8 THR B 249 ILE B 271 1 23 HELIX 27 AC9 LEU B 273 SER B 291 1 19 HELIX 28 AD1 GLY C 21 LYS C 35 1 15 HELIX 29 AD2 SER C 39 PHE C 68 1 30 HELIX 30 AD3 TYR C 70 GLY C 78 1 9 HELIX 31 AD4 ALA C 79 PHE C 90 1 12 HELIX 32 AD5 PRO C 91 GLY C 101 1 11 HELIX 33 AD6 LEU C 104 GLU C 118 1 15 HELIX 34 AD7 LYS C 122 VAL C 148 1 27 HELIX 35 AD8 VAL C 148 GLY C 153 1 6 HELIX 36 AD9 ASN C 164 HIS C 179 1 16 HELIX 37 AE1 THR C 181 LEU C 206 1 26 HELIX 38 AE2 ASP C 208 ALA C 226 1 19 HELIX 39 AE3 HIS C 230 ASN C 245 1 16 HELIX 40 AE4 THR C 249 ILE C 255 1 7 HELIX 41 AE5 ASN C 257 ILE C 271 1 15 HELIX 42 AE6 LEU C 273 GLU C 289 1 17 HELIX 43 AE7 GLY D 21 ALA D 36 1 16 HELIX 44 AE8 SER D 39 PHE D 68 1 30 HELIX 45 AE9 TYR D 70 GLY D 78 1 9 HELIX 46 AF1 ALA D 79 PHE D 90 1 12 HELIX 47 AF2 PRO D 91 GLY D 101 1 11 HELIX 48 AF3 LEU D 104 GLU D 118 1 15 HELIX 49 AF4 LYS D 122 VAL D 148 1 27 HELIX 50 AF5 SER D 149 GLY D 153 5 5 HELIX 51 AF6 ASN D 164 HIS D 179 1 16 HELIX 52 AF7 THR D 181 LEU D 206 1 26 HELIX 53 AF8 ASP D 208 ALA D 226 1 19 HELIX 54 AF9 HIS D 230 VAL D 244 1 15 HELIX 55 AG1 THR D 249 ILE D 255 1 7 HELIX 56 AG2 ASN D 257 ILE D 271 1 15 HELIX 57 AG3 LEU D 273 GLU D 289 1 17 HELIX 58 AG4 GLY E 21 ALA E 36 1 16 HELIX 59 AG5 SER E 39 PHE E 68 1 30 HELIX 60 AG6 TYR E 70 GLY E 78 1 9 HELIX 61 AG7 ALA E 79 PHE E 90 1 12 HELIX 62 AG8 PRO E 91 THR E 100 1 10 HELIX 63 AG9 LEU E 104 GLU E 118 1 15 HELIX 64 AH1 LYS E 122 GLY E 153 1 32 HELIX 65 AH2 ASN E 164 HIS E 179 1 16 HELIX 66 AH3 THR E 181 LEU E 206 1 26 HELIX 67 AH4 ASP E 208 GLY E 227 1 20 HELIX 68 AH5 HIS E 230 VAL E 244 1 15 HELIX 69 AH6 THR E 249 LYS E 256 1 8 HELIX 70 AH7 ASN E 257 ILE E 271 1 15 HELIX 71 AH8 LEU E 273 GLU E 289 1 17 SHEET 1 AA1 5 VAL A 13 SER A 14 0 SHEET 2 AA1 5 VAL D 13 LYS D 16 1 O SER D 14 N VAL A 13 SHEET 3 AA1 5 VAL E 13 LYS E 16 1 O LYS E 16 N VAL D 13 SHEET 4 AA1 5 VAL B 13 LYS B 16 1 N LYS B 16 O VAL E 13 SHEET 5 AA1 5 ILE C 15 LYS C 16 1 O LYS C 16 N VAL B 13 SITE 1 AC1 13 TYR A 31 PHE A 90 ALA A 93 PHE A 94 SITE 2 AC1 13 ILE A 97 ILE A 98 SER A 102 LEU A 104 SITE 3 AC1 13 THR A 106 GLY A 107 VAL A 196 VAL A 220 SITE 4 AC1 13 HIS A 230 SITE 1 AC2 13 TYR B 31 VAL B 54 PHE B 90 ALA B 93 SITE 2 AC2 13 PHE B 94 ILE B 97 ILE B 98 LEU B 104 SITE 3 AC2 13 THR B 106 GLY B 107 VAL B 196 VAL B 220 SITE 4 AC2 13 HIS B 230 SITE 1 AC3 11 TYR C 31 PHE C 90 ALA C 93 PHE C 94 SITE 2 AC3 11 ILE C 98 LEU C 104 THR C 106 GLY C 107 SITE 3 AC3 11 VAL C 196 VAL C 220 HIS C 230 SITE 1 AC4 13 TYR D 31 PHE D 90 ALA D 93 PHE D 94 SITE 2 AC4 13 ILE D 97 ILE D 98 SER D 102 LEU D 104 SITE 3 AC4 13 THR D 106 GLY D 107 VAL D 196 VAL D 220 SITE 4 AC4 13 HIS D 230 SITE 1 AC5 13 TYR E 31 PHE E 90 ALA E 93 PHE E 94 SITE 2 AC5 13 ILE E 98 SER E 102 LEU E 104 THR E 106 SITE 3 AC5 13 GLY E 107 VAL E 196 VAL E 220 PHE E 223 SITE 4 AC5 13 HIS E 230 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000